Ligand Pharmaceuticals Inc. LGND announced it has entered into a worldwide license ... with an average beat of 20.75%. Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year …
Monday, Ligand Pharmaceuticals Inc.(LGND) and Neurogen Corp.(NRGN ... Contingent Value Rights or CVRs under four agreements payable in cash and Ligand's common stock with an estimated value of approximately $11 million. As per …
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that its previously disclosed 1-for-6 reverse stock split has become effective, and will be reflected in the share price beginning …
Ligand Pharmaceuticals (NASDAQ: LGND) reported upbeat earnings for the third quarter ... capital to be opportunistic with potential acquisitions and to repurchase stock.” For the current quarter, Ligand projects earnings of $0.57 to $0.62 per …
The stock increased 1.30% or $1.75 during the last trading session ... decreased its stake in Ligand Pharmaceuticals …
The company has five drug candidates based on small molecules licensed from Ligand Pharmaceuticals ( LGND), which intends to purchase $5 million (9%) worth of shares on the offering. Viking's lead candidate is an oral treatment entering …
Ligand Pharmaceuticals Inc. (LGND) gapped open lower Monday and dropped further in early trade. Shares finished with a loss of 9.81 at $130.50 on strong volume. Ligand Pharmaceuticals dropped below a trading range at the highs of the …